Leaps by Bayer

About

Leaps is the strategic impact investment unit of Bayer. By accelerating transformative biotechnologies, we aim to shift key paradigms in life science, changing the world for better. In health, we pursue breakthroughs that could set new standards in medical care, moving from treating symptoms to curing or preventing diseases. In agriculture, we drive innovations that could nourish a growing population while restoring the planet. It was founded in 2015 and headquartered in Leverkusen, Nordrhein-Westfalen.

Investment Focus

Stages

series-a

Sectors

biotech

Location

Leverkusen, Germany